ips differentiated cardiomyocytes
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2019 (NCT03759405)
Timeline
Indications
Mechanism of action
- MuscleTissue restoration
Muscle tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05068674 | Phase 1 | Jan 31, 2022 | Stanford University |
| NCT03759405 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2019 | Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1